Not Tagged
ONWARD Medical
['lift study']
at the 2023 meeting, jim guest, md, phd, shared that 72% of up-lift study participants were considered responders(1) to arc-ex (2)
(1)participants who met pre-specified primary endpoint responder definition (2)investigational therapy, not available for commercial use 
ONWARD is a medical technology company creating innovative therapies to enable functional recovery for people with spinal cord injuries.
#Neurostimulation #BCI